918153-28-3

Basic information

• Product Name: 3-Nitro-2-pyridineethanol
• Synonyms: 3-Nitro-2-pyridineethanol;2-(3-Nitropyridin-2-yl)ethanol
• CAS NO: 918153-28-3
• Molecular Formula: C7H8N2O3
• Molecular Weight: 168.15002
• Mol File: 918153-28-3.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-Nitro-2-pyridineethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Nitro-2-pyridineethanol(918153-28-3)
• EPA Substance Registry System: 3-Nitro-2-pyridineethanol(918153-28-3)

Safety Data

• Hazardous Substances Data: 918153-28-3(Hazardous Substances Data)

Usage

General Description

3-Nitro-2-pyridineethanol is a chemical compound with the molecular formula C7H8N2O3. It is an organic compound with a nitro group and a pyridine ring, and it also contains an ethanol group. The compound is commonly used in the synthesis of pharmaceuticals and agricultural chemicals. It is considered to have moderate toxicity and can cause irritation to the skin, eyes, and respiratory system. It is important to handle this chemical with caution and follow proper safety procedures when working with it. Overall, 3-Nitro-2-pyr

Upstream product

• 18699-87-1 2-methyl-3-nitropyridine 
• 50-00-0 formaldehyd 

Relevant articles and documents

HETEROCYCLYLAMINOALKYL SUBSTITUTED BENZIMIDAZOLES

Heterocyclylaminoalkyl Substituted Benzimidazoles Inhibitors of RSV replication of formula (I): The salts and stereochemically isomeric forms thereof, wherein Q is hydrogen, C1-6alkyl optionally substituted with a heterocycle or Q is C1 -6alkyl substituted with both -OR4 and a heterocycle; wherein said heterocycle is oxazolidine, thiazolidine, 1-oxo-thiazolidine, 1,1-dioxothiazolidine, morpholinyl, thiomorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxothiomorpholinyl, hexahydrooxazepine, hexahydrothiazepine, 1-oxo-hexahydrothiazepine, 1,1-dioxo-hexahydrothiazepine, pyrrolidine, piperidine, homopiperidine, piperazine; which heterocyle may be substituted with 1-2 substituents; each Alk is C1 -6alkanediyl; R1 is Ar or optionally substituted piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, tetrahydrofuranyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazolyl, isoxazo lyl, oxadiazolyl, quinolinyl, quinoxalinyl, benzofuranyl, benzothienyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, pyridopyridyl, naphthiridinyl, 1H-imidazo[4,5-b]pyridinyl, 3H-imidazo[4,5-b]pyridinyl, imidazo[1,2-a]pyridinyl or 2,3-dihydro-1,4-dioxino[2,3-b]pyridyl; R3 is hydroxyC1 -6alkyl, C1 -6alkoxyC1-6alkyl, cyanoC1-6alkyl, aminocarbonyl-C1 -6-alkyl, mono-or di(C1 -6alkyl)aminocarbonyl-C1 -6- alkyl, carboxyl-C1 -6-alkyl, C1-6alkoxycarbonyl-C1-6 alkyl; R2, R4 and R5 are hydrogen or C1-6alkyl; Het is pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, tetrahydrofuranyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazolyl, isoxazolyl, oxadiazolyl, quinolinyl, quinoxalinyl, benzofuranyl, benzothienyl, benzimidazolyl, benzoxazo lyl, benzthiazolyl, pyridopyridyl, naphthiridinyl, 1H-imidazo[4,5-b]- pyridinyl, 3H-imidazo[4,5-b]pyridinyl, imidazo[1,2-a]pyridinyl and 2,3-dihydro-1,4- dioxino[2,3-b]pyridyl; Ar is optionally substituted phenyl; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I).